Bridge Bank, a division of Western Alliance Bank, has launched a new banking group – Life Sciences Group (LSG) – which will offer customized financial solutions to companies operating in the life sciences sector, including within the biotech, medical devices and pharma verticals.
The Life Sciences Group will focus on providing term and revolving debt to life sciences companies for a variety of purposes including growth and working capital, refinancing, restructuring, recapitalization, as well as for financing mergers and acquisitions.
In addition to providing credit solutions, LSG will offer the full complement of Bridge Bank’s financial solutions including treasury management and international banking services.
Based in San Diego and offering financial solutions to companies nationwide, Bridge Bank’s Life Sciences Group will be led by Robert Lake, a lender with nearly 20 years of commercial lending experience specializing in venture-backed life sciences, technology and healthcare services companies.
Before joining Bridge Bank, Mr. Lake was executive director at Oxford Finance LLC, held leadership positions at Silicon Valley Bank, Fifth Third Bank and the American Medical Association.
Bridge Bank recently announced the formation of its Equity Fund Resources group, whose purpose is to develop an eco-system of centralized resources to both private investors and Bridge Bank clients, including life sciences companies.